Plasma level studies of penbutolol after oral dose in man.
Plasma levels of penbutolol (HOE 893d) were determined in eight healthy adult male subjects after oral administration of 50-mg capsules. Fast absorpiton of the drug from the gastrointestinal tract was indicated by the rapid increase in plasma levels during the absorption phase, with a peak time at about 1 hour after dosing in all subjects. After the peak level, plasma concentrations declined biexponentially, with an average half-life of 2.5 and 27 hours for the fast and slow disposition phases, respectively. These values were in good agreement with data previously found for this drug. Cumulative excretion of intact drug in the urine of the eight subjects during 72 hours after dosing was less than 4 per cent, except for one subject who excreted 9.82 per cent of the dose. Large individual variations were found for area under the plasma level curves, disposition rates, and amounts of intact drug excreted in the urine. Significant pharmacologic effects were noted in all eight subjects at the 50-mg dose level, and mild side effects were evident in one half of these subjects. The average drop in blood pressure and pulse rate for all subjects was 26/18 mm Hg and 19 beats per minute, respectively.
D000284:Administration, Oral; D000319:Adrenergic beta-Antagonists / Q000097:blood* / Q000494:pharmacology / Q000652:urine; D000328:Adult; D001794:Blood Pressure / Q000187:drug effects; D003517:Cyclopentanes / Q000097:blood / Q000494:pharmacology / Q000652:urine; D006801:Humans; D007700:Kinetics; D008297:Male; D011412:Propanolamines / Q000097:blood* / Q000494:pharmacology / Q000652:urine; D011674:Pulse / Q000187:drug effects; D013050:Spectrometry, Fluorescence; D013997:Time Factors
D000319:Adrenergic beta-Antagonists; D003517:Cyclopentanes; D011412:Propanolamines